V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005959 | 220002320 | 1.8 | null | Curative (C) | 2014-03-08 | 2014-08-14 | null | Y | N | 220029332 | NOT MATCHED |
| 220005960 | 220011296 | 0 | null | Curative (C) | 2016-09-22 | 2016-09-22 | Nilotinib | 02 | N | 220029334 | NILOTINIB |
| 220005961 | 220011296 | 1.61 | null | Curative (C) | 2013-11-22 | 2013-11-22 | FLAG + Idarubicin | N | N | 220029334 | FLAG + IDARUBICIN |
| 220005962 | 220011296 | 1.57 | 91.3 | Curative (C) | 2017-12-13 | 2017-12-13 | AML 19 TRIAL | null | null | 220029334 | AML19 TRIAL |
| 220005963 | 220002321 | 1.72 | null | Disease modification (D) | 2018-05-19 | 2018-05-19 | Nilotinib | N | N | 220029339 | NILOTINIB |
| 220005964 | 220002321 | 1.68 | 105.5 | Curative (C) | 2015-12-06 | 2015-12-09 | AML 19 TRIAL | Y | null | 220029339 | AML19 TRIAL |
| 220005965 | 220002321 | 1.56 | 104.5 | Curative (C) | 2017-07-08 | 2017-07-08 | AML 19 TRIAL | 1 | N | 220029339 | AML19 TRIAL |
| 220005966 | 220002322 | null | 0 | Disease modification (D) | 2016-03-02 | 2016-03-03 | Nilotinib | N | N | 220029347 | NILOTINIB |
| 220005967 | 220002322 | 0 | 0 | Curative (C) | 2013-01-29 | 2013-01-29 | FBC Conditionining | N | null | 220029347 | NOT MATCHED |
| 220005968 | 220002322 | 1.8 | 72.1 | Curative (C) | 2017-07-10 | 2017-07-11 | AML 19 TRIAL | Y | N | 220029347 | AML19 TRIAL |
| 220005969 | 220002323 | 1.61 | 106.2 | Curative (C) | 2016-09-22 | 2016-09-22 | AML 19 TRIAL | Y | N | 220029355 | AML19 TRIAL |
| 220005970 | 220002323 | 1.65 | 97.4 | Curative (C) | 2016-07-01 | 2016-07-01 | AML 19 TRIAL | Y | N | 220029355 | AML19 TRIAL |
| 220005972 | 220002324 | null | 116.6 | Curative (C) | 2013-04-22 | 2013-04-22 | AML 19 TRIAL | N | N | 220029359 | AML19 TRIAL |
| 220005973 | 220002324 | 1.6 | 14.2 | Curative (C) | 2018-01-21 | 2019-02-28 | Quizartinib (AC220) | 1 | N | 220029359 | NOT MATCHED |
| 220005974 | 220002324 | null | null | null | 2013-09-29 | 2013-10-02 | Nilotinib | N | N | 220029359 | NILOTINIB |
| 220005975 | 220002325 | null | 0 | Adjuvant (A) | 2013-10-16 | 2013-10-17 | Nilotinib | N | N | 220029364 | NILOTINIB |
| 220005976 | 220002326 | 1.63 | 72.1 | Curative (C) | null | 2013-03-21 | FLAG + Idarubicin | N | N | 220029366 | FLAG + IDARUBICIN |
| 220005977 | 220002327 | 1.82 | 0 | Not known (9) | 2015-10-30 | 2015-10-30 | Nilotinib | 02 | N | 220029367 | NILOTINIB |
| 220005978 | 220002328 | 1.77 | 22.7 | Curative (C) | 2015-10-25 | 2015-10-29 | APML Consolidation II ATRA,Idarubicin | 02 | N | 220029368 | NOT MATCHED |
| 220005979 | 220002329 | 0 | null | Curative (C) | 2014-09-29 | 2014-10-03 | Nilotinib | N | N | 220029369 | NILOTINIB |
| 220005980 | 220011301 | null | 56.2 | Curative (C) | 2017-12-06 | 2017-12-06 | AML 19 TRIAL | N | N | 220029372 | AML19 TRIAL |
| 220005981 | 220011301 | 1.73 | 73 | Disease modification (D) | 2017-04-17 | 2017-04-23 | FLAG + Idarubicin | null | null | 220029372 | FLAG + IDARUBICIN |
| 220005982 | 220002330 | 1.67 | 106 | Curative (C) | 2016-04-14 | 2016-04-14 | AML 19 TRIAL | Y | N | 220029376 | AML19 TRIAL |
| 220005983 | 220002331 | 1.75 | 83.7 | Curative (C) | 2015-10-17 | 2015-10-18 | AML 19 TRIAL | N | N | 220029381 | AML19 TRIAL |
| 220005984 | 220002331 | null | 78.5 | Disease modification (D) | 2017-09-01 | 2017-09-01 | Nilotinib | N | N | 220029381 | NILOTINIB |
| 220005985 | 220002331 | 1.77 | 76.4 | Curative (C) | 2013-03-16 | 2013-03-16 | AML 19 TRIAL | Y | N | 220029381 | AML19 TRIAL |
| 220005986 | 220002332 | 1.66 | 76.7 | Curative (C) | 2017-08-26 | 2017-08-26 | AML 19 TRIAL | 01 | null | 220029389 | AML19 TRIAL |
| 220005987 | 220002333 | null | 10 | Curative (C) | 2013-01-14 | 2013-02-15 | CYTARABINE + Hydroxycarbamide | 2 | N | 220029391 | NOT MATCHED |
| 220005988 | 220002333 | 1.87 | 107 | Curative (C) | 2015-04-30 | 2015-05-01 | AML 19 TRIAL | N | N | 220029391 | AML19 TRIAL |
| 220005989 | 220002334 | 1.63 | 75 | Curative (C) | 2017-11-05 | 2017-11-09 | FLAG + Idarubicin | 2 | N | 220029393 | FLAG + IDARUBICIN |
| 220005990 | 220002334 | 1.6 | 108 | Curative (C) | 2017-05-27 | 2017-05-30 | AML 19 TRIAL | 01 | null | 220029393 | AML19 TRIAL |
| 220005991 | 220002335 | 1.73 | 55 | Curative (C) | 2013-02-28 | 2013-02-28 | FLAG + Idarubicin | Y | N | 220029397 | FLAG + IDARUBICIN |
| 220005992 | 220002335 | 1.67 | 101 | Curative (C) | null | 2014-12-27 | AML Interim Guidelines FLAG-Ida | N | N | 220029397 | FLAG + IDARUBICIN |
| 220005993 | 220002336 | null | 61.3 | Curative (C) | 2017-01-21 | 2017-01-25 | APML Cons ATO + ATRA | 2 | N | 220029400 | NOT MATCHED |
| 220005994 | 220011306 | 1.64 | 63.6 | Curative (C) | 2016-02-10 | 2016-02-10 | AML 19 TRIAL | N | N | 220029403 | AML19 TRIAL |
| 220005995 | 220011306 | 0 | 0 | Curative (C) | 2014-10-05 | 2014-10-19 | Nilotinib | 02 | N | 220029403 | NILOTINIB |
| 220005996 | 220002337 | 1.7 | 94.2 | Curative (C) | 2017-08-11 | 2017-08-11 | FLAG + Idarubicin | N | N | 220029408 | FLAG + IDARUBICIN |
| 220005997 | 220002337 | 0 | 0 | Disease modification (D) | 2016-05-13 | 2016-08-15 | Nilotinib | 02 | N | 220029408 | NILOTINIB |
| 220005998 | 220002337 | null | 0 | Disease modification (D) | 2014-07-13 | 2014-07-13 | Nilotinib | 2 | N | 220029408 | NILOTINIB |
| 220005999 | 220018791 | 1.59 | 98 | Curative (C) | 2013-01-24 | 2013-02-04 | Nilotinib | 2 | N | 220029416 | NILOTINIB |
| 220006000 | 220002338 | null | 79.3 | Curative (C) | 2015-09-30 | 2015-09-30 | AML Interim Guidelines FLAG-Ida | N | N | 220029420 | FLAG + IDARUBICIN |
| 220006001 | 220011308 | 1.83 | 60.3 | Disease modification (D) | 2013-05-23 | 2013-05-24 | AML 19 TRIAL | Y | N | 220029423 | AML19 TRIAL |
| 220006002 | 220011308 | 1.62 | null | Curative (C) | 2017-04-13 | 2017-04-22 | AML Interim Guidelines FLAG-Ida | N | N | 220029423 | FLAG + IDARUBICIN |
| 220006003 | 220002339 | null | null | null | 2015-03-31 | 2015-03-31 | FLAG + Idarubicin | null | N | 220029425 | FLAG + IDARUBICIN |
| 220006004 | 220002339 | 1.84 | 78.5 | Curative (C) | 2013-02-28 | 2013-03-04 | AML 19 TRIAL | Y | N | 220029425 | AML19 TRIAL |
| 220006005 | 220002340 | 1.56 | 77 | Curative (C) | 2018-04-03 | 2018-04-03 | Nilotinib | N | N | 220029427 | NILOTINIB |
| 220006006 | 220002340 | null | 85 | Disease modification (D) | 2013-03-30 | 2013-04-03 | AML 19 TRIAL | Y | N | 220029427 | AML19 TRIAL |
| 220006007 | 220002340 | 1.78 | 77.5 | Curative (C) | 2014-11-11 | 2014-11-21 | FLAG + Idarubicin | N | N | 220029427 | FLAG + IDARUBICIN |
| 220006008 | 220002340 | 1.7 | 0 | Curative (C) | 2016-12-15 | 2016-12-15 | Nilotinib | null | N | 220029427 | NILOTINIB |
| 220006009 | 220002341 | 0 | 85 | Disease modification (D) | 2016-04-28 | 2016-04-28 | Nilotinib | 2 | N | 220029438 | NILOTINIB |